News – Page 498 – Endpoints News

BlackRock joins Andrew Lo's risk analysis firm to search for odds-on biotech bets in turbulent times

3 years ago

Editas hires top Sanofi scientist for CMO as C-suite shuffle continues

3 years ago

Immunocore is the latest to nab a private placement, securing $140M to pursue more TCR R&D

3 years ago

An old epilepsy med gets oral liquid formulation nod; PMV pairs up ASCO standout with Keytruda

3 years ago

Weeks after rare disease drug got spurned, Acer returns to FDA for second shot

3 years ago

Sesen Bio pauses bladder cancer drug work, offloads eye disease antibodies to Roche

3 years ago

Eliem delays a depression trial, indefinitely postpones another after blaming CMC issues for low drug exposure

3 years ago

Sanofi waves the white flag on Regulus' microRNA program targeting rare kidney disease

3 years ago

Samsung’s CDMO arm commits to $324M land purchase for a second bio campus

3 years ago

Oxford Science Enterprises collects $300M to offer spinouts 'scale-up capital'

3 years ago

DNA sequencing giant Illumina battles antitrust regulators and growing competition

3 years ago

Nestlé puts down $40M, kicks off deal with gut microbiome specialist to fight food allergies

3 years ago

Novartis' big PD-1 bet turns sour; $350M resurrection story; Contraceptive for men heads to clinic; and more

3 years ago

US government orders 2.5M more monkeypox vaccine doses from Bavarian Nordic via CMO

3 years ago

Merck KGaA kicks off startup collaboration program in Asia

3 years ago

Pfizer celebrates a new FDA approval as the Xalkori franchise slowly winds down

3 years ago

J&J objects to Sanofi’s '#1 Doctor Recommended' claims about heartburn drug Zantac

3 years ago

Illumina strikes $325M deal to end years-long patent battles

3 years ago

Pfizer's Hospira issues a recall for a batch of propofol due to a visible particulate

3 years ago

FDA user fee bill deadline falls apart? Thousands of pink slips for FDA could be coming as Burr seeks to start anew

3 years ago

Canadian CRO Altasciences kicks off client manufacturing expansion in Philadelphia

3 years ago

Kyowa Kirin pulls the plug on drug development for successor to Parkinson's drug Nourianz

3 years ago

As the consumer group splits away today, what will New GSK buy now?

3 years ago

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

3 years ago

First page Previous page 495 496 497498499 500 501 Next page Last page